Skip to main content

Cystic Fibrosis: Treatment

  • Chapter
  • First Online:
Pediatric Respiratory Diseases

Abstract

Cystic fibrosis treatment is based on a symptomatic approach aimed to interrupt the cycle of mucus retention, infection, and inflammation. The treatment must start early in life to avoid permanent damage to the lung. Treatment for cystic fibrosis requires a multidisciplinary team and a specialized center where patients can carry out their follow-up. The main treatment must be based on nutrition, antibiotic treatment, and chest physiotherapy. Nutritional support is essential for both quality of life and survival. Chest physiotherapy is recommended to improve airway secretions management, essential for symptomatic relief, with inhaled treatment. Therapy must also target respiratory infections, and the use of antibiotics will depend on the clinician’s objective, such as treatment for first bacterial isolation, acute exacerbations, chronic suppressive therapy, or prophylactic treatment. New therapies may be considered, such as genetic pharmacotherapy for certain mutations and antiinflammatory treatment, but they are not considered as standard of care. Oxygen therapy and ventilation support are recommended when chronic lung damage is present and lung transplant becomes an option to improve survival.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Sources

  • Borowitz D, Robinson KA, Rosenfeld M, Davis SD, Sabadosa KA, Spear SL, Michel SH, Parad RB, White TB, Farrell PM, Marshall BC, Accurso FJ. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr. 2009;155:S73–93.

    Article  Google Scholar 

  • Conway S, Balfour-Lynn IM, De Rijcke K, Drevinek P, Foweraker J, Havermans T, et al. European Cystic Fibrosis Society Standards of Care: framework for the Cystic Fibrosis Centre. J Cyst Fibros. 2014;13(suppl 1):S3–S22.

    Article  Google Scholar 

  • Döring G, Flume P, Heijerman H, Elborn JS. Treatment of lung infection in patients with cystic fibrosis: current and future strategies. J Cyst Fibros. 2012;11:461–79.

    Article  Google Scholar 

  • Flume PA, Mogayzel PJ Jr, Robinson KA, Goss CH, Rosenblatt RL, Kuhn RJ, Marshall BC. Cystic fibrosis pulmonary guidelines. Treatment of pulmonary exacerbations. Am J Respir Crit Care Med. 2009;180:802–8.

    Article  Google Scholar 

  • Flume PA, Robinson KA, O’Sullivan BP, Finder JD, Vender RL, Willey-Courand DB, White TB, Marshall BC. Cystic fibrosis pulmonary guidelines: airway clearance therapies. Respir Care. 2009;54(4):522–37.

    PubMed  Google Scholar 

  • Heijerman H, Westerman E, Conway S, Döring DT. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: a European consensus. J Cyst Fibros. 2009;8:295–315.

    Article  CAS  Google Scholar 

  • Kerem E, Conway S, Elborn S, Heijerman H. Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros. 2005;4:7–26.

    Article  Google Scholar 

  • Mogayzel PJ Jr, Naureckas ET, Robinson KA, Mueller G, Hadjiliadis D, Hoag JB, Lubsch L, Hazle L, Sabadosa K, Marshall B. Cystic fibrosis pulmonary guidelines, chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2013;187(7):680–9.

    Article  Google Scholar 

  • O’Sullivan BP, Freedman SD. Cystic fibrosis. Lancet. 2009;373:1891–904.

    Article  Google Scholar 

  • Sinaasappel M, Stern M, Littlewood J, Wolfe S, Steinkamp G, Heijerman HG, Robberecht E, Doring G. Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibros. 2002;1:51–75.

    Article  CAS  Google Scholar 

  • Smyth AR, Bell SC, Bojcin S, Bryon M, Duff A, Flume P, et al. European Cystic Fibrosis Society Standards of Care: best practice guidelines. J Cyst Fibros. 2014;13(suppl 1):S23–42.

    Article  Google Scholar 

  • Stern M, Bertrand DP, Bignamini E, Corey M, Dembski B, Goss CH, et al. European Cystic Fibrosis Society Standards of Care: quality management in cystic fibrosis. J Cyst Fibros. 2014;13(suppl 1):S43–59.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Felix Ratjen .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ratjen, F., Pizarro Gamboa, M.E. (2020). Cystic Fibrosis: Treatment. In: Bertrand, P., Sánchez, I. (eds) Pediatric Respiratory Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-26961-6_45

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-26961-6_45

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-26960-9

  • Online ISBN: 978-3-030-26961-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics